| Manager | Title | Age | Since |
|---|---|---|---|
Scott Thomson
CEO | Chief Executive Officer | - | 2024-06-16 |
James Steele
DFI | Director of Finance/CFO | - | - |
Timothy Curl
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rakesh Sachdev
CHM | Chairman | 70 | 2019-05-31 |
| Director/Board Member | 59 | - | |
Charles Kummeth
BRD | Director/Board Member | 65 | 2022-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +13.61% | - | - | 3.08M | |
| +0.85% | -0.80% | +52.79% | +159.97% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.41% | 609B | |
| +0.04% | +2.58% | +34.47% | +84.84% | 450B | |
| 0.00% | +1.39% | +31.18% | +22.46% | 330B | |
| -0.67% | -0.06% | +35.99% | +36.89% | 284B | |
| -0.42% | -0.30% | +22.87% | +17.54% | 263B | |
| -0.04% | +1.86% | -19.58% | -40.15% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.85% | 198B | |
| -1.48% | +3.43% | +24.08% | +70.06% | 167B | |
| Average | -0.26% | +0.54% | +28.96% | +52.10% | 397.23B | |
| Weighted average by Cap. | -0.13% | +0.02% | +37.82% | +78.09% |
Employees
-
Sector
Pharmaceuticals
